Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder
Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder
Active, not recruiting · NCT05529901 · Registry updated 2025-11-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cryptogenic Ischemic Stroke, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, ischemic stroke, nervous system disorder, patent foramen ovale, stroke disorder, transient ischemic attack, vascular disorder | Active, not recruiting | Not stated | 2025-11-20 | NCT05529901 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| W.L.Gore & Associates | 44 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Okayama University Hospital | Okayama | Japan | 75 |